<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03584581</url>
  </required_header>
  <id_info>
    <org_study_id>PI2016/13 nº 77</org_study_id>
    <nct_id>NCT03584581</nct_id>
  </id_info>
  <brief_title>Effects on Lipid Metabolism of Olive Extracts Rich in Polyphenols</brief_title>
  <official_title>Effects on Lipid Metabolism of Olive Extracts Rich in Polyphenols</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Miguel Hernandez de Elche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Miguel Hernandez de Elche</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to determine whether a standardized intervention in the health center
      and based on hygienic dietary measures and physical exercise, supplemented with a polyphenol
      extract in patients, achieves a greater benefit in the reduction of LDL cholesterol in
      dyslipidemias in the short term.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cholesterols levels</measure>
    <time_frame>1 month</time_frame>
    <description>TC, HDL-C, LDL-C and TG.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BMI (kg/m2)</measure>
    <time_frame>1 month</time_frame>
    <description>Weight and height will be combined to report BMI in kg/m^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>1 month</time_frame>
    <description>SBP and DBP.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference (cm)</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cholesterol; Metabolic Disorder</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Olive polyphenols</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Olive polyphenols</intervention_name>
    <description>The amount of polyphenols to be supplied is within the ranges of absolute biosecurity food described by different authors and used in different studies.</description>
    <arm_group_label>Olive polyphenols</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with dyslipidemia without the need for pharmacological treatment, but with
             annual follow-up of their dyslipidemia and with baseline LDL-cholesterol values.

          -  Patients to whom the annual analysis will be carried out for control of the lipid
             profile and who agree to postpone it during the month of the health education study.

          -  Patients who undergo hygienic-dietetic intervention and exercise.

          -  Patients willing to ingest the nutritional supplement of polyphenols that will be
             supplied to them.

          -  Signed the informed consent.

        Exclusion Criteria:

          -  &lt;18 years old.

          -  High cardiovascular risk.

          -  With pharmacological treatment.

          -  With some previous chronic disease.

          -  With some allergy to the compounds of the product and placebo according to the
             technical specifications.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ernesto Cortés-Castell, PhD</last_name>
    <phone>+34966658500</phone>
    <email>ernesto.cortes@umh.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>General University Hospital of Elda</name>
      <address>
        <city>Elda</city>
        <state>Alicante</state>
        <zip>03690</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicente F Gil-Guillén, MD, PhD</last_name>
      <phone>+34966975017</phone>
      <email>vte.gil@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ernesto Cortés-Castell, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonio Palazón-Bru, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>María M Rizo-Baeza, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vicente F Gil-Guillén, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luís Torró-Montell, MPharm</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Enrique Hermida-Campa, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Tangney CC, Rasmussen HE. Polyphenols, inflammation, and cardiovascular disease. Curr Atheroscler Rep. 2013 May;15(5):324. doi: 10.1007/s11883-013-0324-x. Review.</citation>
    <PMID>23512608</PMID>
  </reference>
  <reference>
    <citation>Bleys J, Miller ER 3rd, Pastor-Barriuso R, Appel LJ, Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2006 Oct;84(4):880-7; quiz 954-5.</citation>
    <PMID>17023716</PMID>
  </reference>
  <reference>
    <citation>Halliwell B, Rafter J, Jenner A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am J Clin Nutr. 2005 Jan;81(1 Suppl):268S-276S. doi: 10.1093/ajcn/81.1.268S. Review.</citation>
    <PMID>15640490</PMID>
  </reference>
  <reference>
    <citation>Obied HK, Prenzler PD, Konczak I, Rehman AU, Robards K. Chemistry and bioactivity of olive biophenols in some antioxidant and antiproliferative in vitro bioassays. Chem Res Toxicol. 2009 Jan;22(1):227-34. doi: 10.1021/tx8004168.</citation>
    <PMID>19099401</PMID>
  </reference>
  <reference>
    <citation>Covas MI, Fitó M, Lamuela-Raventós RM, Sebastiá N, de la Torre-Boronat C, Marrugat J. Virgin olive oil phenolic compounds: binding to human low density lipoprotein (LDL) and effect on LDL oxidation. Int J Clin Pharmacol Res. 2000;20(3-4):49-54.</citation>
    <PMID>11314237</PMID>
  </reference>
  <reference>
    <citation>Veciana Galindo C, Cortés Castell E, Torro Montell L, Sirvent Segura E, Rizo Baeza MM, Gil Guillén V. [Assessment of cytotoxicity and biosafety of polyphenolic extracts from olive pits]. Nutr Hosp. 2014 Jun 1;29(6):1388-93. doi: 10.3305/nh.2014.29.6.7141. Spanish.</citation>
    <PMID>24972479</PMID>
  </reference>
  <reference>
    <citation>Cortés Castell E, Veciana Galindo C, Torro Montell L, Sirvent Segura E, Rizo Baeza MM, Gil Guillén V. [Anti-inflammatory activity of olive seed polyphenolic extract in the THP1-XBLUE-CD14 human monocytes cell line]. Nutr Hosp. 2014 Jul 1;30(1):113-7. doi: 10.3305/nh.2014.30.1.7482. Spanish.</citation>
    <PMID>25137269</PMID>
  </reference>
  <reference>
    <citation>Veciana-Galindo C, Cortés-Castell E, Torró-Montell L, Palazón-Bru A, Sirvent-Segura E, Rizo-Baeza MM, Gil-Guillén VF. Anti-adipogenic activity of an olive seed extract in mouse fibroblasts. Nutr Hosp. 2015 Jun 1;31(6):2747-51. doi: 10.3305/nh.2015.31.6.8997.</citation>
    <PMID>26040391</PMID>
  </reference>
  <reference>
    <citation>Cortés Castell E, Veciana Galindo C, Torro Montell L, Sirvent Segura E, Rizo Baeza MM, Gil Guillén V. [Effect on zebrafish neurodevelopment and neuroprotection of a polyphenolic extract olive seeds]. Nutr Hosp. 2014 Aug 1;30(2):338-42. doi: 10.3305/nh.2014.30.2.7604. Spanish.</citation>
    <PMID>25208788</PMID>
  </reference>
  <reference>
    <citation>Perrinjaquet-Moccetti T, Busjahn A, Schmidlin C, Schmidt A, Bradl B, Aydogan C. Food supplementation with an olive (Olea europaea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytother Res. 2008 Sep;22(9):1239-42. doi: 10.1002/ptr.2455.</citation>
    <PMID>18729245</PMID>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 27, 2018</study_first_submitted>
  <study_first_submitted_qc>July 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2018</study_first_posted>
  <last_update_submitted>July 11, 2018</last_update_submitted>
  <last_update_submitted_qc>July 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Miguel Hernandez de Elche</investigator_affiliation>
    <investigator_full_name>Ernesto Cortés-Castell</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The data will not be publicly available.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

